SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/292796"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/292796" > The long-term effec...

The long-term effect of isradipine in pindolol-treated patients.

Dahlöf, Björn, 1953 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Andrén, Lennart, 1946 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Eggertsen, Robert, 1948 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
visa fler...
Jern, Sverker, 1954 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
SVensson, Anders (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Hansson, Lennart (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
visa färre...
 (creator_code:org_t)
1987
1987
Engelska.
Ingår i: Journal of hypertension. Supplement : official journal of the International Society of Hypertension. - 0952-1178. ; 5:5, s. S567-70
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The long-term efficacy of isradipine, a new dihydropyridine calcium antagonist with marked vascular selectivity, was evaluated in 17 patients with essential hypertension. All had a supine diastolic blood pressure of greater than 95 mmHg with 10 mg pindolol once daily. After a short-term, double-blind, dose-finding, crossover comparison with addition of isradipine or placebo twice daily, they continued on pindolol and their optimal dose of isradipine in a single-blind, long-term follow-up study. Eighteen patients were recruited but one male patient discontinued treatment after 2 weeks due to ankle oedema and will not be accounted for in the overall evaluation. There were 11 males and six females with a mean age of 56 +/- 10 years. In the short-term study on the optimal dose of isradipine (5.1 mg twice daily) blood pressure was lowered by 24/18 mmHg (P less than 0.001). No change in heart rate was seen despite the substantial drop in blood pressure. In the long-term study the patients were seen for a mean follow-up time of 12.5 months (range 4-17 months). After the longest follow-up time mean arterial pressure was 107.0 +/- 7.4 compared with 120.1 +/- 8.2 mmHg after placebo baseline [delta = 13 mmHg (11%), P less than 0.001, n = 17]. The heart rate was unchanged (delta = 0.2 beats/min, 95% confidence limits -3, +3), and so was ankle circumference (delta = 0.12 cm, 95% confidence interval, -1, +1). On the other hand, mean weight was reduced by 2 kg from 90 kg (P less than 0.05, n = 17).(ABSTRACT TRUNCATED AT 250 WORDS)

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Allmänmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- General Practice (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Aged
Body Weight
drug effects
Calcium Channel Blockers
adverse effects
therapeutic use
Double-Blind Method
Drug Therapy
Combination
Edema
etiology
Female
Heart Rate
drug effects
Humans
Hypertension
drug therapy
Isradipine
Male
Middle Aged
Pindolol
administration & dosage
Pyridines
adverse effects
therapeutic use

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy